Polarean Imaging Ltd (POLX) ORD GBP0.00037
Share news, reports & tips
12 November 2019 16:02
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Tuesday that it has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system...
7 November 2019 11:51
(Sharecast News) - Medical imaging technology company Polarean Imaging, which has a proprietary magnetic resonance imaging (MRI) drug-device combination, announced on Thursday that the enrolment for its...
5 August 2019 08:32
(Sharecast News) - Medical-imaging technology company Polarean has enrolled its first patient in the third trial of its proprietary drug-device combination product at the University of Cincinnati.
27 June 2019 10:02
(Sharecast News) - Polarean Imaging's shares climbed on Thursday after reporting that its annual revenues doubled to come in slightly above expectations as sales in the US soared.
29 April 2019 09:24
(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.
15 February 2019 10:27
(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on...
11 December 2018 13:41
(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.
23 August 2018 14:53
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate...
27 July 2018 09:26
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the allowance of the latest patents on polarisation, the results of a 'pilot study' that was undertaken in...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.